These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31526687)

  • 21. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
    Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
    Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital Mammography Has Persistently Increased High-Grade and Overall DCIS Detection Without Altering Upgrade Rate.
    Neal CH; Joe AI; Patterson SK; Pujara AC; Helvie MA
    AJR Am J Roentgenol; 2021 Apr; 216(4):912-918. PubMed ID: 33594910
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
    Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
    Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm.
    Ha R; Chang P; Karcich J; Mutasa S; Van Sant EP; Connolly E; Chin C; Taback B; Liu MZ; Jambawalikar S
    Ann Surg Oncol; 2018 Oct; 25(10):3037-3043. PubMed ID: 29978368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fully Automated Postlumpectomy Breast Margin Assessment Utilizing Convolutional Neural Network Based Optical Coherence Tomography Image Classification Method.
    Mojahed D; Ha RS; Chang P; Gan Y; Yao X; Angelini B; Hibshoosh H; Taback B; Hendon CP
    Acad Radiol; 2020 May; 27(5):e81-e86. PubMed ID: 31324579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI-guided quadrantectomy in patients with ductal carcinoma in situ detected preoperatively by mammographic calcifications.
    Sakakibara M; Yokomizo J; Shiina N; Kazama T; Nakamura R; Fujimoto H; Nagashima T; Takishima H; Nakatani Y; Miyazaki M
    J Am Coll Surg; 2014 Aug; 219(2):295-302. PubMed ID: 24880957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
    Grimm LJ; Ghate SV; Hwang ES; Soo MS
    Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Apparent Diffusion Coefficient to Predict Grade, Microinvasion, and Invasion in Ductal Carcinoma In Situ of the Breast.
    Hussein H; Chung C; Moshonov H; Miller N; Kulkarni SR; Scaranelo AM
    Acad Radiol; 2015 Dec; 22(12):1483-8. PubMed ID: 26391856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
    Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
    Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
    Woodard GA; Price ER
    AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting invasion in mammographically detected microcalcification.
    Bagnall MJ; Evans AJ; Wilson AR; Pinder SE; Denley H; Geraghty JG; Ellis IO
    Clin Radiol; 2001 Oct; 56(10):828-32. PubMed ID: 11895299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
    Wahedna Y; Evans AJ; Pinder SE; Ellis IO; Blamey RW; Geraghty JG
    Eur J Cancer; 2001 Mar; 37(4):459-62. PubMed ID: 11267854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
    Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
    Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
    Stomper PC; Geradts J; Edge SB; Levine EG
    AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
    Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.